[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334388-105":59,"doc-detail-334388-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","the-incidence-of-secondary-neoplasms-in-retinoblastoma-survivors-who-underwent-radiation-therapy-a-systematic-review-and-meta-analysis","The incidence of secondary neoplasms in retinoblastoma survivors who underwent radiation therapy - A systematic review and meta-analysis","","Secondary neoplasms are a major cause of mortality among retinoblastoma survivors, especially after radiation exposure. This systematic review and meta-analysis evaluates the association between radiation therapy and the incidence of secondary neoplasms in retinoblastoma survivors. Searches were conducted in PubMed, ProQuest, and EBSCOhost, including English-language studies with a non-radiotherapy control group. Five studies with 3324 patients met inclusion criteria; 8.72% developed secondary neoplasms, and radiotherapy recipients had a pooled risk ratio of 5.12.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/the-incidence-of-secondary-neoplasms-in-retinoblastoma-survivors-who-underwent-radiation-therapy-a-systematic-review-and-meta-analysis/334388/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/the-incidence-of-secondary-neoplasms-in-retinoblastoma-survivors-who-underwent-radiation-therapy-a-systematic-review-and-meta-analysis/334388.png","ImageObject",300,407,{"name":92,"@type":93},"Valentina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main research question of this systematic review?","Question",{"text":112,"@type":113},"Whether radiation exposure is associated with a higher incidence of secondary neoplasms in retinoblastoma survivors.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which studies and patient groups were included or excluded?",{"text":117,"@type":113},"Included studies were English-language and reported retinoblastoma patients with and without radiotherapy using a control group; animal studies and studies without a control group were excluded.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the meta-analysis find about the risk of secondary neoplasms?",{"text":121,"@type":113},"Patients who received radiotherapy had a higher risk, with a pooled risk ratio of 5.12 (95% CI 3.56–7.36; I2 = 14%).","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334388,1790188553,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":4},13056703020460,"https://ap-avatar.wpscdn.com/avatar/be000253dac470eee5d?_k=1778207105932848923","| Access this article online |\n| --- |\n| Quick Response Code: |\n| |\n| Website:\u003Cbr>[http://journals.lww.com/TJOP](http://journals.lww.com/TJOP) |\n| DOI:\u003Cbr>10.4103/tjo.TJO-D-23-00086 |\n\n1Research Assistant, Pediatric Ophthalmology Division, Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia – Dr. Cipto Mangunkusumo Hospital, 2Pediatric Ophthalmologist, Pediatric Ophthalmology Division, Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia – Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia  \n*Address for correspondence:  \nDr. Anthea Casey, M. D. , Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia – Dr. Cipto Mangunkusumo Hospital, Kimia Street No. 8-10, Menteng, Central Jakarta, Indonesia, 10320.  \nE-mail: antheacasey@ [yahoo.co.id](yahoo.co.id)  \nSubmission: 23-06-2023  \nAccepted: 24-12-2023  \nPublished: 02-02-2024  \nReview Article: Systematic Review  \nTaiwan J Ophthalmol 2025;15:45‑54  \nThe incidence of secondary neoplasms in retinoblastoma survivors who underwent radiation therapy:  \nA systematic review and meta‑analysis  \nAnthea Casey1*, Julie Dewi Barliana2  \nAbstract:  \nSecondary neoplasms are a significant cause of mortality among retinoblastoma survivors, particularly when exposed to radiation. This systematic review aims to investigate the association between radiation exposure and the incidence of secondary neoplasms in retinoblastoma survivors. A comprehensive literature search was conducted using PubMed, ProQuest, and EBSCOhost databases to gather relevant studies. Studies written in English about the incidence of secondary neoplasms in retinoblastoma patients who underwent radiotherapy were included. Retinoblastoma patients who did not receive radiotherapy were regarded as the control group. Studies involving animals and those without a control group were excluded. No date restrictions were applied. The last search was performed on April 6, 2022. The study selection process was presented in a flow diagram following the Preferred Reporting Items of Systematic reviews Meta‑Analysis 2020 guidelines. The risk of bias was evaluated using the Risk of Bias in nonrandomized Studies of Interventions tool. Statistical analysis was performed using the Cochrane RevMan software (version 5.4.1) . Five studies comprising a total of 3324 retinoblastoma patients were included. Of these, 290 (8.72%) patients developed secondary neoplasms, with 250 (86.21%) receiving radiotherapy. The results indicated that retinoblastoma patients who received radiotherapy had a higher risk of developing secondary neoplasms, with a pooled risk ratio of 5.12 (95% confidence interval 3.56–7.36, I2 = 14%) . The findings of this review highlight the importance of considering the risk of developing secondary neoplasms when treating retinoblastoma. Regular medical surveillance for secondary neoplasms should be a standard part of care for retinoblastoma survivors, particularly those exposed to radiation.  \nKeywords:  \nRadiation, retinoblastoma, secondary neoplasms  \nIntroduction  \nRetinoblastoma is the most common  \nform of childhood intraocular malignancy with an incidence of one case per 15,000–20,000 live births worldwide.[1] In 2013, a study found that 43% of the global burden of retinoblastomawasin six countries in the Asian‑Pacific region, with Indonesia being the third highest. [2] In developed countries, the survival rate is over 95%, and treatments have shifted from preserving  \nThis is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution‑NonCommercial‑ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non‑commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.  \nFor reprints [contact:](contact: WKHLRPMedknow_reprints@wolterskluwer.com)[ WKHLRPMedknow_reprints@wolterskluwer.com](contact: WKHLRPMedknow_reprints@wolterskluwer.com)  \nthe globe to ","cbCaio33GnqqKl4h","https://ap.wps.com/l/cbCaio33GnqqKl4h","pdf",1474482,"English","# Abstract\n# Introduction\n# Methods\n## Search strategy and selection criteria","[{\"question\":\"What is the main research question of this systematic review?\",\"answer\":\"Whether radiation exposure is associated with a higher incidence of secondary neoplasms in retinoblastoma survivors.\"},{\"question\":\"Which studies and patient groups were included or excluded?\",\"answer\":\"Included studies were English-language and reported retinoblastoma patients with and without radiotherapy using a control group; animal studies and studies without a control group were excluded.\"},{\"question\":\"What did the meta-analysis find about the risk of secondary neoplasms?\",\"answer\":\"Patients who received radiotherapy had a higher risk, with a pooled risk ratio of 5.12 (95% CI 3.56–7.36; I2 = 14%).\"}]","The incidence of secondary neoplasms in retinoblastoma survivors who underwent radiation therapy - A systematic review and meta-analysis | PDF",1790006458,25]